In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Laura Leavitt is a personal finance and wellness writer for CNET. Her work has been published at NextAdvisor, Bankrate, The Simple Dollar, MoneyGeek, Business Insider and more. Amelia Ti is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results